{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:29:55Z","timestamp":1794360595209,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"crossref","award":["UPPM\/226\/M\/05.04\/05.17"],"award-info":[{"award-number":["UPPM\/226\/M\/05.04\/05.17"]}],"id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Duchenne\/Becker muscular dystrophy (DMD\/BMD) is the most common genetic neuromuscular disease in children, resulting from a defect in the <jats:italic>DMD<\/jats:italic> gene located on Xp21.2. The new emerging treatment using exon skipping strategy is tailored to specific mutations, thus molecular diagnostics are particularly important. This study aimed to detect the <jats:italic>DMD<\/jats:italic> gene deletion in Indonesian DMD\/BMD patients and analyze the potential amenability by exon skipping therapy.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-four male patients were enrolled in this study, 23 of them (67.6%) underwent muscle biopsy and showed the absence or partially expressed dystrophin protein in immunohistochemistry staining. All patients had very high serum CK levels (10.529\u2009\u00b1\u20099.97\u00a0IU\/L). Multiplex PCR revealed the <jats:italic>DMD<\/jats:italic> gene deletions in 15 (44.1%) cases. Seventy-eight percent of deletions were clustered in the hot-spot region of exon 43 to 52. Furthermore, seven (20.5%) patients were potentially amenable to exon skipping treatment. Therefore, multiplex PCR is one feasible method to detect <jats:italic>DMD<\/jats:italic> gene deletion in Indonesian DMD\/BMD patients that can further determine the potential amenability of exon skipping therapy. In addition, this study is the first report of <jats:italic>DMD<\/jats:italic> gene deletion analysis in Indonesia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-019-4730-1","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T15:05:26Z","timestamp":1572275126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD\/BMD patients: the era of personalized medicine"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5116-3809","authenticated-orcid":false,"given":"Kristy","family":"Iskandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ery Kus","family":"Dwianingsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pratiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Santoso","family":"Kalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasna","family":"Mardhiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alifiani H.","family":"Putranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian K.","family":"Nurputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agung","family":"Triono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth S.","family":"Herini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusdy G.","family":"Malueka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gunadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh San","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sunartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"4730_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"A Emery","year":"1991","unstructured":"Emery A. Population frequencies of inherited neuromuscular diseases\u2014a world survey. Neuromuscul Disord. 1991;1:19\u201329.","journal-title":"Neuromuscul Disord"},{"key":"4730_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(17)30399-X","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:211\u20132.","journal-title":"Lancet Neurol."},{"key":"4730_CR3","first-page":"117","volume":"31","author":"S Rall","year":"2012","unstructured":"Rall S, Grimm T. Survival in Duchenne muscular dystrophy. Acta Myol. 2012;31:117\u201320.","journal-title":"Acta Myol."},{"key":"4730_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0197205","volume":"13","author":"F Mohammed","year":"2018","unstructured":"Mohammed F, et al. Mutation spectrum analysis of Duchenne\/Becker muscular dystrophy in 68 families in Kuwait: the era of personalized medicine. PloS one. 2018;13:1\u201311. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0197205\n                    \n                  .","journal-title":"PloS one."},{"key":"4730_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00438-014-0847-z","volume":"289","author":"Y Wang","year":"2014","unstructured":"Wang Y, et al. Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy. Mol Genet Genomics. 2014;289:1013\u201321.","journal-title":"Mol Genet Genomics"},{"key":"4730_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","volume":"53","author":"A Aartsma-Rus","year":"2016","unstructured":"Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet. 2016;53:145\u201351.","journal-title":"J Med Genet"},{"key":"4730_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/jhg.2010.49","volume":"55","author":"Y Takeshima","year":"2010","unstructured":"Takeshima Y, et al. Mutation spectrum of the dystrophin gene in 442 Duchenne\/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet. 2010;55:379\u201388.","journal-title":"J Hum Genet"},{"issue":"8","key":"4730_CR8","first-page":"2471","volume":"2016","author":"Y Shimizu-Motohashi","year":"2016","unstructured":"Shimizu-Motohashi Y, Miyatake S, Komaki H, Takeda S, Aoki Y. Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials. Am J Transl Res. 2016;2016(8):2471\u201389.","journal-title":"Am J Transl Res"},{"key":"4730_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol."},{"issue":"5","key":"4730_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/jmg.28.5.304","volume":"28","author":"S Abbs","year":"1991","unstructured":"Abbs S, Yau SC, Clark S, Mathew CG, Bobrow M. A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. J med Genet. 1991;28(5):304\u201311.","journal-title":"J med Genet"},{"key":"4730_CR11","first-page":"272","volume-title":"PCR protocols: a guide to methods and applications","author":"JS Chamberlain","year":"1990","unstructured":"Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press; 1990. p. 272\u201381."},{"key":"4730_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00205170","volume":"86","author":"A Beggs","year":"1990","unstructured":"Beggs A, Koenig M, Boyce F, Kunkel L. Detection of 98% of DMD\/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45\u20138.","journal-title":"Hum Genet"},{"key":"4730_CR13","unstructured":"CureDuchenneTM. Duchenne population potentially amenable to exon skipping.\u00a0\n                    https:\/\/www.cureduchenne.org\/wp-content\/uploads\/2016\/11\/Duchenne-Population-Potentially-Amenable-to-Exon-Skipping-11.10.16.pdf\n                    \n                  ."},{"key":"4730_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd003725.pub4","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur A. Corticosteroid therapy for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016.\u00a0\n                    https:\/\/doi.org\/10.1002\/14651858.cd003725.pub4\n                    \n                  .","journal-title":"Cochrane Database Syst Rev."},{"key":"4730_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrg3460","volume":"14","author":"RJ Fairclough","year":"2013","unstructured":"Fairclough RJ, Wood MJ, Davies KE. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet. 2013;14:373\u20138.","journal-title":"Nat Rev Genet"},{"key":"4730_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/nat.2017.0682","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus A, et al. Development of exon skipping therapies for Duchenne Muscular dystrophy: a critical review and a perspective on the outstanding issues. Nucleic Acid Ther. 2017;27:251\u20139.","journal-title":"Nucleic Acid Ther."},{"key":"4730_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.braindev.2015.05.014","volume":"38","author":"M Matsuo","year":"2016","unstructured":"Matsuo M, Takeshima Y, Nishio H. Contributions of Japanese patients to development of antisense therapy for DMD. Brain Dev. 2016;38:4\u20139. \n                    https:\/\/doi.org\/10.1016\/j.braindev.2015.05.014\n                    \n                   (Epub 2015).","journal-title":"Brain Dev."},{"key":"4730_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell JR, et al. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol. 2016;79:257\u201371.","journal-title":"Ann Neurol"},{"key":"4730_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s100380200084","volume":"47","author":"PS Lai","year":"2002","unstructured":"Lai PS, et al. Comparative study on deletions of the dystrophin gene in three asian populations. J Hum Genet. 2002;47:552\u20135.","journal-title":"J Hum Genet"},{"key":"4730_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1155\/2008\/521568","volume":"25","author":"T Sura","year":"2008","unstructured":"Sura T, Eu-ahsunthornwattana J, Pingsuthiwong S, Busabaratana M. Sensitivity and frequencies of dystrophin gene mutations in Thai DMD\/BMD patients as detected by multiplex PCR. Dis Markers. 2008;25:115\u201321.","journal-title":"Dis Markers"},{"issue":"9","key":"4730_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/jmg.29.9.647","volume":"29","author":"F Rininsland","year":"1992","unstructured":"Rininsland F, et al. Identification of a new DMD gene deletion by ectopic transcript analysis. J Med Genet. 1992;29(9):647\u201351.\u200b","journal-title":"J Med Genet."},{"key":"4730_CR22","first-page":"675","volume":"51","author":"AE Covone","year":"1992","unstructured":"\u200bCovone AE, Caroli F, Romeo G. Screening Duchenne and\u00a0Becker muscular dystrophy patients for deletions in 30 exons of the dystrophin gene by three-multiplex PCR. Am J Hum Genet. 1992;51:675\u20137.","journal-title":"Am J Hum Genet."}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4730-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:32:03Z","timestamp":1603758723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4730-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4730"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4730-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethical Committee of Faculty of Medicine, Universitas Gadjah Mada\/Dr. Sardjito Hospital gave approval for this study (KE\/FK\/1164\/EC\/2017). The patients were ascertained for this study after their parents signed a written informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"704"}}